MALAT-1 is Associated with the Doxorubicin Resistance in U-2OS Osteosarcoma Cells
Chang Liu,1,2,* Xuesong Han,1,* Bo Li,2,* Shaobin Huang,1 Zhong Zhou,1 Zhiwei Wang,2 Wanming Wang1 1Department of Orthopedics, The 900th Hospital of Joint Logistic Support Force, Fuzhou, Fujian Province, 350025, People’s Republic of China; 2Department of Orthopedics, Changhai...
Main Authors: | Liu C, Han X, Li B, Huang S, Zhou Z, Wang Z, Wang W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/malat-1-is-associated-with-the-doxorubicin-resistance-in-u-2os-osteosa-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
Long Noncoding RNA MALAT-1 Enhances Stem Cell-Like Phenotypes in Pancreatic Cancer Cells
by: Feng Jiao, et al.
Published: (2015-03-01) -
A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines
by: Fateme Haghiralsadat, et al.
Published: (2017-05-01) -
Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma
by: Yang P, et al.
Published: (2020-08-01) -
LncRNA MALAT1: A Potential Fibrosis Biomarker and Therapeutic Target
by: Yijie Li, et al.
Published: (2021-02-01) -
Nuclear-Encoded lncRNA MALAT1 Epigenetically Controls Metabolic Reprogramming in HCC Cells through the Mitophagy Pathway
by: Yijing Zhao, et al.
Published: (2021-03-01)